Literature DB >> 20596974

Fascin over expression is associated with dysplastic changes in sinonasal inverted papillomas: a study of 47 cases.

Hope H Wu1, Samiah Zafar, Youming Huan, Herman Yee, Luis Chiriboga, Beverly Y Wang.   

Abstract

Sinonasal inverted papilloma (IP) is a primary benign lesion with a tendency for local recurrence. Malignant transformation may develop in up to 15% of cases. Fascin (Fascin 1) is an actin cross-link binding protein required for the formation of actin-based cell-surface protrusions and cell motility. Fascin up-regulation in lung, gastric, breast and hepatobiliary carcinomas correlates with aggressiveness and decreased survival. Here we evaluate immunohistochemical expression of fascin in 47 sinonasal IPs from 34 patients. Fascin over-expression is significantly more common in sinonasal IP with high-grade dysplasia than in those with no dysplastic or low-grade dysplastic epithelium (P = 0.0001). No significant change in fascin expression is seen with recurrence. Over expression of fascin in high-grade dysplastic epithelium in IP may be associated with tumor progression and malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20596974      PMCID: PMC2811625          DOI: 10.1007/s12105-009-0133-2

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  29 in total

Review 1.  Fascins, and their roles in cell structure and function.

Authors:  Nina Kureishy; Vasileia Sapountzi; Soren Prag; N Anilkumar; Josephine Clare Adams
Journal:  Bioessays       Date:  2002-04       Impact factor: 4.345

Review 2.  The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence.

Authors:  William Lawson; Nicolas F Schlecht; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2008-04-23

3.  Inverted papilloma: a report of 112 cases.

Authors:  W Lawson; B T Ho; C M Shaari; H F Biller
Journal:  Laryngoscope       Date:  1995-03       Impact factor: 3.325

4.  Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma.

Authors:  Giuseppe Altavilla; Alberto Staffieri; Graziella Busatto; Alessandra Canesso; Luciano Giacomelli; Gino Marioni
Journal:  Acta Otolaryngol       Date:  2009-11       Impact factor: 1.494

5.  Loss of basal cell keratin 14 reflects increased risk of recurrence in surgically resected sinonasal inverted papilloma.

Authors:  S Gunia; D Liebe; S Koch
Journal:  J Clin Pathol       Date:  2008-06       Impact factor: 3.411

6.  Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.

Authors:  Tomohiro Iguchi; Shinichi Aishima; Akinobu Taketomi; Yunosuke Nishihara; Nobuhiro Fujita; Kensaku Sanefuji; Keishi Sugimachi; Yo-ichi Yamashita; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2008-10-05       Impact factor: 3.466

Review 7.  Roles of fascin in cell adhesion and motility.

Authors:  Josephine C Adams
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

8.  Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness.

Authors:  Foteini Karasavvidou; Sotirios Barbanis; Dimitra Pappa; George Moutzouris; Vasilios Tzortzis; Michael D Melekos; George Koukoulis
Journal:  Arch Pathol Lab Med       Date:  2008-12       Impact factor: 5.534

Review 9.  Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis.

Authors:  Tawee Tanvetyanon; Dahui Qin; Tapan Padhya; Rachna Kapoor; Judith McCaffrey; Andy Trotti
Journal:  Am J Otolaryngol       Date:  2008-07-22       Impact factor: 1.808

10.  Preparation and purification of polymerized actin from sea urchin egg extracts.

Authors:  R E Kane
Journal:  J Cell Biol       Date:  1975-08       Impact factor: 10.539

View more
  8 in total

1.  Advances in recurrence and malignant transformation of sinonasal inverted papillomas.

Authors:  Qingjia Sun; Lifeng An; Jun Zheng; Dongdong Zhu
Journal:  Oncol Lett       Date:  2017-04-24       Impact factor: 2.967

2.  Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion.

Authors:  Ziyun Gao; Qiuhang Zhang; Feng Kong; Ge Chen; Mingchu Li; Hongchuan Guo; Jiantao Liang; Yuhai Bao; Feng Ling
Journal:  Med Oncol       Date:  2012-02-16       Impact factor: 3.064

Review 3.  Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review.

Authors:  M Re; F M Gioacchini; A Bajraktari; M Tomasetti; S Kaleci; C Rubini; A Bertini; G Magliulo; E Pasquini
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-21       Impact factor: 2.503

4.  Transitional neoplasms of the naso-lacrimal system: A review of the histopathology and histogenesis.

Authors:  J Godfrey Heathcote
Journal:  Saudi J Ophthalmol       Date:  2012-04

5.  Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma.

Authors:  Banu Dogan Gun; Burak Bahadir; Sibel Bektas; Figen Barut; Gamze Yurdakan; Nilufer Onak Kandemir; Sukru Oguz Ozdamar
Journal:  Diagn Pathol       Date:  2012-07-11       Impact factor: 2.644

6.  Clinical evidence based review and systematic scientific review in the identification of malignant transformation of inverted papilloma.

Authors:  Cai Long; Basel Jabarin; Alexandra Harvey; Jennifer Ham; Amin Javer; Arif Janjua; Andrew Thamboo
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-04-30

7.  Skull base inverted papilloma: a comprehensive review.

Authors:  Shafik N Wassef; Pete S Batra; Samuel Barnett
Journal:  ISRN Surg       Date:  2012-12-31

8.  IMP3 Immunohistochemical Expression in Inverted Papilloma and Inverted Papilloma-Associated Sinonasal Squamous Cell Carcinoma.

Authors:  Sarah A Hakim; Nermine M Abd Raboh; Lobna S Shash
Journal:  Anal Cell Pathol (Amst)       Date:  2021-02-16       Impact factor: 2.916

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.